Evidence map›Paper›PMID 36501379›Full record

ArticlePlants (Basel, Switzerland)2022

Niko S Radulović, Marko Z Mladenović, Dušan R Vukićević, Nikola M Stojanović, Pavle J Randjelović, Zorica Z Stojanović-Radić, Fabio Boylan

Open access · goldAbstract read
In one paragraph

Article in Plants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. New Aromatic Abietane Diterpenoids fromMolecules (Basel, Switzerland) · 2026
    Article
  2. Unlocking the Secrets of Roman Chamomile (Molecules (Basel, Switzerland) · 2026
    Article
  3. New Oxygenated Methoxy-Molecules (Basel, Switzerland) · 2025
    Article
  4. Chemical profile, antiproliferative and pro-apoptotic activities of essential oils ofSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Article
  5. Article
  6. The genome sequence of common fleabane,Wellcome open research · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Niko S RadulovićDepartment of Chemistry, Faculty of Sciences and Mathematics, University of Nis, Višegradska 33, 18000 Nis, Serbia.ORCID 0000-0003-1342-7567
Marko Z MladenovićDepartment of Chemistry, Faculty of Sciences and Mathematics, University of Nis, Višegradska 33, 18000 Nis, Serbia.
Dušan R VukićevićFaculty of Medicine, University of Kragujevac, Svetozara Markovića 69, 34000 Kragujevac, Serbia.
Nikola M StojanovićDepartment of Physiology, Faculty of Medicine, University of Nis, Zorana Ðinđica 81, 18000 Nis, Serbia.ORCID 0000-0002-0124-3501
Pavle J RandjelovićDepartment of Physiology, Faculty of Medicine, University of Nis, Zorana Ðinđica 81, 18000 Nis, Serbia.ORCID 0000-0002-4569-1787
Zorica Z Stojanović-RadićDepartment of Biology and Ecology, Faculty of Sciences and Mathematics, University of Nis, Visegradska 33, 18000 Nis, Serbia.
Fabio BoylanSchool of Pharmacy and Pharmaceutical Sciences, Panoz Institute, Trinity College, Westland Row, 2 Dublin, Ireland.ORCID 0000-0001-5531-1787
University of Nis · RSTrinity College Dublin · IEUniversity of Kragujevac · RS

Funding

Ministry of Education, Science and Technological Development of the Republic of Serbia 451-03-68/2022-14/200124 and 451-03-68/2022-14/200113
6 · The paper itself

Abstract

Motivated by the ethnopharmacological use of

Indexed as

3-methoxycuminyl estersacetylcholinesterase inhibitory activityantimicrobial activityantispasmodic activityessential oilPulicaria dysenterica

Identifiers

PMID36501379
PMCPMC9739903
OpenAlexW4311105734

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.